Literature DB >> 18800034

Challenges and opportunities for local and systemic delivery of siRNA and antisense oligonucleotides.

L Sepp-Lorenzino1, Mk Ruddy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18800034     DOI： 10.1038/clpt.2008.174

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  22 in total

1.  Quantitative evaluation of siRNA delivery in vivo.

Authors:  Yi Pei; Paula J Hancock; Hangchun Zhang; René Bartz; Craig Cherrin; Nathalie Innocent; Colin J Pomerantz; Jessica Seitzer; Martin L Koser; Marc T Abrams; Yan Xu; Nelly A Kuklin; Paul A Burke; Alan B Sachs; Laura Sepp-Lorenzino; Stanley F Barnett
Journal:  RNA       Date:  2010-10-12       Impact factor: 4.942

2.  Noninvasive imaging of lipid nanoparticle-mediated systemic delivery of small-interfering RNA to the liver.

Authors:  Weikang Tao; Joseph P Davide; Mingmei Cai; Guo-Jun Zhang; Victoria J South; Andrea Matter; Bruce Ng; Ye Zhang; Laura Sepp-Lorenzino
Journal:  Mol Ther       Date:  2010-07-13       Impact factor: 11.454

Review 3.  Technologies for investigating the physiological barriers to efficient lipid nanoparticle-siRNA delivery.

Authors:  Bin Shi; Marc Abrams
Journal:  J Histochem Cytochem       Date:  2013-03-14       Impact factor: 2.479

4.  Biodistribution of small interfering RNA at the organ and cellular levels after lipid nanoparticle-mediated delivery.

Authors:  Bin Shi; Ed Keough; Andrea Matter; Karen Leander; Stephanie Young; Ed Carlini; Alan B Sachs; Weikang Tao; Marc Abrams; Bonnie Howell; Laura Sepp-Lorenzino
Journal:  J Histochem Cytochem       Date:  2011-08       Impact factor: 2.479

Review 5.  Cytokines as biomarkers of nanoparticle immunotoxicity.

Authors:  Mahmoud Elsabahy; Karen L Wooley
Journal:  Chem Soc Rev       Date:  2013-06-21       Impact factor: 54.564

Review 6.  Theranostic small interfering RNA nanoparticles in cancer precision nanomedicine.

Authors:  Zhihang Chen; Balaji Krishnamachary; Jesus Pachecho-Torres; Marie-France Penet; Zaver M Bhujwalla
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2019-10-23

7.  Mechanistically probing lipid-siRNA nanoparticle-associated toxicities identifies Jak inhibitors effective in mitigating multifaceted toxic responses.

Authors:  Weikang Tao; Xianzhi Mao; Joseph P Davide; Bruce Ng; Mingmei Cai; Paul A Burke; Alan B Sachs; Laura Sepp-Lorenzino
Journal:  Mol Ther       Date:  2010-12-21       Impact factor: 11.454

8.  Evaluation of efficacy, biodistribution, and inflammation for a potent siRNA nanoparticle: effect of dexamethasone co-treatment.

Authors:  Marc T Abrams; Martin L Koser; Jessica Seitzer; Stephanie C Williams; Martha A DiPietro; Weimin Wang; Andrew W Shaw; Xianzhi Mao; Vasant Jadhav; Joseph P Davide; Paul A Burke; Alan B Sachs; Steven M Stirdivant; Laura Sepp-Lorenzino
Journal:  Mol Ther       Date:  2009-09-08       Impact factor: 11.454

9.  Calculation of hydrodynamic properties for G-quadruplex nucleic acid structures from in silico bead models.

Authors:  Huy T Le; Robert Buscaglia; William L Dean; Jonathan B Chaires; John O Trent
Journal:  Top Curr Chem       Date:  2013

10.  Peptide-functionalized nanogels for targeted siRNA delivery.

Authors:  William H Blackburn; Erin B Dickerson; Michael H Smith; John F McDonald; L Andrew Lyon
Journal:  Bioconjug Chem       Date:  2009-05-20       Impact factor: 4.774
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.